
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Step by step instructions to Protect Your Retirement with Senior Protection. - 2
At UN climate conference, some activists and scientists want more talk on reforming agriculture - 3
Mexico says a third of 130,000 missing people might be alive, fueling criticism from families - 4
US FDA grants market authorization to six on! PLUS nicotine pouch products - 5
The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
South Carolina measles outbreak grows by nearly 100, spreads to North Carolina and Ohio
Tech for Learning: Online Courses and Instructive Apparatuses
Artemis 2 astronauts head for the moon after make-or-break engine burn (video)
10 Setting up camp Shelters That Offer Both Excellence and Isolation
Activists guilty over Palestine protest breach
Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide
Striking American and European television Projects: A Survey
Ukraine to get up to 100 French-made Rafale fighter jets













